• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.炎症性肠病门诊患者的贫血:患病率、危险因素及病因
Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925. Epub 2015 Feb 1.
2
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.斯堪的纳维亚半岛炎症性肠病门诊患者贫血和缺铁的患病率。
Scand J Gastroenterol. 2011 Mar;46(3):304-9. doi: 10.3109/00365521.2010.533382. Epub 2010 Nov 15.
3
Characterization of acquired anemia in children by iron metabolism parameters.铁代谢参数对儿童获得性贫血的特征描述。
Sci Rep. 2022 Feb 17;12(1):2721. doi: 10.1038/s41598-022-06574-0.
4
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.瑞士炎症性肠病患者贫血患病率的横断面研究:来自私人诊所和大学医院的患者。
J Crohns Colitis. 2010 Dec;4(6):642-8. doi: 10.1016/j.crohns.2010.07.008. Epub 2010 Aug 12.
5
ANEMIA AND IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A REFERRAL CENTER IN BRAZIL: PREVALENCE AND RISK FACTORS.巴西转诊中心炎症性肠病患者的贫血和缺铁症:患病率及危险因素。
Arq Gastroenterol. 2020 Jul-Sep;57(3):272-277. doi: 10.1590/S0004-2803.202000000-51.
6
Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.炎症性肠病中的贫血:患病率、鉴别诊断及其与临床和实验室指标的关联
Sao Paulo Med J. 2014;132(3):140-6. doi: 10.1590/1516-3180.2014.1323568. Epub 2014 Apr 14.
7
Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease.抗 TNF-α 治疗对炎症性肠病患者血红蛋白水平及贫血的影响。
Dig Liver Dis. 2020 Apr;52(4):400-407. doi: 10.1016/j.dld.2019.11.019. Epub 2019 Dec 28.
8
Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.土耳其炎症性肠病患者贫血的频率、类型和治疗方法。
World J Gastroenterol. 2018 Sep 28;24(36):4186-4196. doi: 10.3748/wjg.v24.i36.4186.
9
Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.血小板增多与炎症性肠病中铁缺乏性贫血的关系。
Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1212-6. doi: 10.1097/MEG.0b013e328363e354.
10
Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease.评估炎症性肠病贫血时网织红细胞和红细胞指数的测量。
J Crohns Colitis. 2011 Aug;5(4):295-300. doi: 10.1016/j.crohns.2011.02.002. Epub 2011 Apr 3.

引用本文的文献

1
Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease.炎症性肠病住院患者贫血的临床和实验室特征
J Clin Med. 2023 Mar 23;12(7):2447. doi: 10.3390/jcm12072447.
2
Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review.炎症性肠病中的缺铁性贫血——一篇叙述性综述。
Nutrients. 2021 Nov 10;13(11):4008. doi: 10.3390/nu13114008.
3
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.治疗炎症性肠病缺铁性贫血的干预措施。
Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD013529. doi: 10.1002/14651858.CD013529.pub2.
4
Calprotectin in inflammatory bowel disease.炎症性肠病中的钙卫蛋白
Clin Chim Acta. 2020 Nov;510:556-565. doi: 10.1016/j.cca.2020.08.025. Epub 2020 Aug 18.
5
Patients developing inflammatory bowel disease have iron deficiency and lower plasma ferritin years before diagnosis: a nested case-control study.炎症性肠病患者在诊断前数年就存在缺铁和血浆铁蛋白水平降低的情况:一项巢式病例对照研究。
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1147-1153. doi: 10.1097/MEG.0000000000001816.
6
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.联合使用常见粪便和血液标志物检测内镜下活动性炎症性肠病
Clin Transl Gastroenterol. 2020 Mar;11(3):e00138. doi: 10.14309/ctg.0000000000000138.
7
Blood concentrations and renal clearance of water-soluble vitamins in outpatients with ulcerative colitis.溃疡性结肠炎门诊患者水溶性维生素的血药浓度及肾清除率
Biomed Rep. 2019 Mar;10(3):202-210. doi: 10.3892/br.2019.1191. Epub 2019 Feb 5.
8
Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010-2014.2010 - 2014年美国儿童炎症性肠病的贫血筛查、患病率及治疗情况
Pediatr Gastroenterol Hepatol Nutr. 2019 Mar;22(2):152-161. doi: 10.5223/pghn.2019.22.2.152. Epub 2019 Feb 27.
9
Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.土耳其炎症性肠病患者贫血的频率、类型和治疗方法。
World J Gastroenterol. 2018 Sep 28;24(36):4186-4196. doi: 10.3748/wjg.v24.i36.4186.
10
Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.美国 2010-2014 年炎症性肠病患者静脉铁输注后的不良反应。
Inflamm Bowel Dis. 2018 Jul 12;24(8):1801-1807. doi: 10.1093/ibd/izy063.

本文引用的文献

1
Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.炎症性肠病中的贫血:患病率、鉴别诊断及其与临床和实验室指标的关联
Sao Paulo Med J. 2014;132(3):140-6. doi: 10.1590/1516-3180.2014.1323568. Epub 2014 Apr 14.
2
Anemia in inflammatory bowel disease: a neglected issue with relevant effects.炎症性肠病中的贫血:一个被忽视但具有相关影响的问题。
World J Gastroenterol. 2014 Apr 7;20(13):3542-51. doi: 10.3748/wjg.v20.i13.3542.
3
Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis.欧洲国家炎症性肠病贫血患病率:系统评价与个体患者数据荟萃分析
Inflamm Bowel Dis. 2014 May;20(5):936-45. doi: 10.1097/01.MIB.0000442728.74340.fd.
4
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.炎症性肠病中的贫血:基于人群的 10 年随访。
Aliment Pharmacol Ther. 2014 Jan;39(1):69-76. doi: 10.1111/apt.12541. Epub 2013 Oct 31.
5
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.硫唑嘌呤或美沙拉嗪治疗对亚闭塞性回肠末端克罗恩病患者再住院发生率的影响。
Med Sci Monit. 2013 Aug 30;19:716-22. doi: 10.12659/MSM.889196.
6
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.炎症性肠病中的贫血和缺铁:一项关于诊断、用羧麦芽糖铁治疗及生活质量的开放性前瞻性观察研究
Scand J Gastroenterol. 2013 Sep;48(9):1027-32. doi: 10.3109/00365521.2013.819442. Epub 2013 Jul 29.
7
Extraintestinal manifestations and complications in IBD.炎症性肠病的肠外表现和并发症。
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.
8
Iron deficiency anaemia: a review of diagnosis, investigation and management.缺铁性贫血:诊断、检查和治疗的综述。
Eur J Gastroenterol Hepatol. 2012 Feb;24(2):109-16. doi: 10.1097/MEG.0b013e32834f3140.
9
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.生物标志物在炎症性肠病的诊断和治疗中的应用。
Gastroenterology. 2011 May;140(6):1817-1826.e2. doi: 10.1053/j.gastro.2010.11.058.
10
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.斯堪的纳维亚半岛炎症性肠病门诊患者贫血和缺铁的患病率。
Scand J Gastroenterol. 2011 Mar;46(3):304-9. doi: 10.3109/00365521.2010.533382. Epub 2010 Nov 15.

炎症性肠病门诊患者的贫血:患病率、危险因素及病因

Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.

作者信息

Antunes Carla Valéria de Alvarenga, Hallack Neto Abrahão Elias, Nascimento Cristiano Rodrigo de Alvarenga, Chebli Liliana Andrade, Moutinho Ivana Lúcia Damásio, Pinheiro Bruno do Valle, Reboredo Maycon Moura, Malaguti Carla, Castro Antonio Carlos Santana, Chebli Júlio Maria Fonseca

机构信息

Division of Gastroenterology, Department of Medicine, Inflammatory Bowel Diseases Center, University Hospital of the Federal University of Juiz de Fora, University of Juiz de Fora School of Medicine, Avenida Eugênio do Nascimento s/n°, Dom Bosco, 36038-330 Juiz de Fora, MG, Brazil.

出版信息

Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925. Epub 2015 Feb 1.

DOI:10.1155/2015/728925
PMID:25705682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4331158/
Abstract

UNLABELLED

Anemia is common in inflammatory bowel disease (IBD). However, epidemiological studies of nonwestern IBD populations are limited and may be confounded by demographic, socioeconomic, and disease-related influences. This study evaluated the prevalence, risk factors, and etiology of anemia in Brazilian outpatients with IBD.

METHODS

In this cross-sectional study, 100 Crohn's disease (CD) patients and 100 ulcerative colitis (UC) subjects were assessed. Anemia workup included complete blood count, ferritin, transferrin saturation, serum levels of folic acid and vitamin B12, and C-reactive protein (CRP) concentration.

RESULTS

The overall prevalence of anemia in IBD was 21%. There was no significant difference in the prevalence of anemia between CD subjects (24%) and UC (18%). Moderate disease activity (OR: 3.48, 95% CI, 1.95-9.64, P = 0.002) and elevated CRP levels (OR: 1.8, 95% CI, 1.04-3.11, P = 0.02) were independently associated with anemia. The most common etiologies of anemia found in both groups were iron deficiency anemia (IDA; 10% on CD and 6% on UC) followed by the anemia of chronic disease (ACD; 6% for both groups).

CONCLUSIONS

In Brazilian IBD outpatients, anemia is highly concurrent condition. Disease moderate activity as well as increased CRP was strongly associated with comorbid anemia. IDA and/or ACD were the most common etiologies.

摘要

未标注

贫血在炎症性肠病(IBD)中很常见。然而,对非西方IBD人群的流行病学研究有限,且可能受到人口统计学、社会经济和疾病相关因素的影响。本研究评估了巴西IBD门诊患者贫血的患病率、危险因素和病因。

方法

在这项横断面研究中,对100例克罗恩病(CD)患者和100例溃疡性结肠炎(UC)患者进行了评估。贫血检查包括全血细胞计数、铁蛋白、转铁蛋白饱和度、叶酸和维生素B12血清水平以及C反应蛋白(CRP)浓度。

结果

IBD患者中贫血的总体患病率为21%。CD患者(24%)和UC患者(18%)的贫血患病率无显著差异。中度疾病活动(比值比:3.48,95%置信区间,1.95 - 9.64,P = 0.002)和CRP水平升高(比值比:1.8,95%置信区间,1.04 - 3.11,P = 0.02)与贫血独立相关。两组中发现的贫血最常见病因是缺铁性贫血(IDA;CD组为10%,UC组为6%),其次是慢性病贫血(ACD;两组均为6%)。

结论

在巴西IBD门诊患者中,贫血是一种高度并发的病症。疾病中度活动以及CRP升高与合并贫血密切相关。IDA和/或ACD是最常见的病因。